A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Parkinson’s patients and their families are increasingly turning to genetic testing to learn more about their disease or risk of passing it on. But testing is complex, and counseling is advised.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Memories "lost" to Alzheimer's disease may just be hard to retrieve, suggests a new study by neuroscientists at Columbia University Irving Medical Center.
Spinal muscular atrophy is partly due to defects in the sensory neuron synapses that activate motor neurons. Symptoms may be reduced by improving synapse function.